openPR Logo

Press Releases from BOC Sciences (10 total)

Prof. Gang Zheng to Share Insights on Theranostic Lipid Nanoparticles in Exclusi …

BOC Sciences hosts Prof. Gang Zheng in a groundbreaking webinar on theranostic lipid nanoparticles for cancer medicine. BOC Sciences announces an upcoming webinar featuring Prof. Gang

BOC Sciences Unveils Comprehensive Capabilities of Custom Peptide Drug Conjugate

BOC Sciences, a leading CRO in the USA, unveils its comprehensive capabilities for custom peptide drug conjugate from project design to commercial production. With its

BOC Sciences Confirms Bulk Offering of Pharmaceutical Impurities for Global Part …

In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards

High-Standard Fermented Raw Materials that Satisfy the Quality Attributes of Hea …

New York, United States-Oct 12, 2022-Managing raw materials as part of the quality system will ensure that all finished healthcare products can meet quality attributes.

Optimal Peptides of BOC Sciences Arouse Heated Discussions at TIDES USA 2022

BOC Sciences successfully participated in TIDES USA 2022 from May 9th to 12th, at Hynes Convention Center, Boston. During the four-day exhibition, experts from BOC

A Collection of Current In-Demand COVID-19 Related Products

As the COVID-19 pandemic keeps spreading around the world with no sign of slowing down, massive research about drugs, vaccines, and other therapies is in

BOC Sciences Provides PseudoUridines for Vaccine R&D

BOC Sciences, a vaccine raw material supplier headquartered in New York, announces providing pseudoUridine products for RNA modification to further promote the research and development

BOC Sciences Improves Its Fermentation CDMO Platform for Microbial Drug Developm …

BOC Sciences, a provider of CDMO services for the development of microbial drugs, recently announced that it has improved its fermentation CDMO platform to provide

BOC Sciences Diversifies Immune Checkpoint Inhibitors and Nonspecific Immune Sti …

Headquartered in Shirley, New York, the world’s reputed chemical supplier BOC Sciences announced to diversify its immune checkpoint inhibitors as well as nonspecific immune stimulation

BOC Sciences Launched Impurities for Scientific Research

BOC Sciences, headquartered in Shirley, New York, announced that a rich collection of impurities are now available for scientific research use on July 27, 2018.

Go To Page: